You are signed out
Join Innoget to connect with Pascal Mayer and thousands
of innovation-driven professionals and organizations
My background encompasses several research, management, founder and executive positions in academia, multinational pharmaceutical companies and start-ups. I co-authored 17 peer-reviewed publications and 12 patent applications, comprising princeps patents protecting Illumina's massively parallel sequencing technology. I earned my Ph.D in macromolecular biophysics from the Louis Pasteur University (now Université de Strasbourg), in Strasbourg (France).
Alphanosos is active in animal feed, medical foods, and pharma, and with the right venture partners, to become a leader in botanical plant-based natural antimicrobial control, well-being and medicine through its R&D based on proprietary Artificial Intelligence. Alphanosos’ first patent-pending disco[…]
Alphanosos’ AI guided rapid discovery technology, validated in antimicrobials and anticancer, is expected to develop within 3 weeks of experimental work with a virology partner an anti-COVID-19 treatment composed of a synergistic mix of extracts of edible plants, chosen for being available in large […]